Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bristol-Myers Squibb
(NY:
BMY
)
44.14
+0.20 (+0.46%)
Streaming Delayed Price
Updated: 1:04 PM EDT, May 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
5,619,509
Open
43.97
Bid (Size)
44.14 (3)
Ask (Size)
44.15 (31)
Prev. Close
43.94
Today's Range
43.73 - 44.47
52wk Range
43.93 - 68.99
Shares Outstanding
2,222,113,553
Dividend Yield
5.17%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration
Today 8:00 EDT
Two-year extension for research and development of alpha-beta T cell medicines for the treatment of cancer and autoimmune diseases
From
Editas Medicine, Inc.
Via
GlobeNewswire
3 Top ETFs to Buy for Passive Income in May
Today 6:32 EDT
These ETFs provide investors with above-average income streams.
Via
The Motley Fool
Topics
ETFs
Performance
YTD
-16.34%
-16.34%
1 Month
-16.70%
-16.70%
3 Month
-10.63%
-10.63%
6 Month
-14.34%
-14.34%
1 Year
-35.47%
-35.47%
More News
Read More
A Closer Look at Bristol-Myers Squibb's Options Market Dynamics
April 30, 2024
Via
Benzinga
How Is The Market Feeling About Bristol-Myers Squibb?
April 29, 2024
Via
Benzinga
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
April 29, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Bristol Myers Squibb Stock Is Sinking Today
April 25, 2024
Via
The Motley Fool
Last Week's Worst-Performing Stocks: Are These 10 Large-Cap Stocks In Your Portfolio? (April 21-27, 2024)
April 28, 2024
Via
Benzinga
Peeling Back The Layers: Exploring Bristol-Myers Squibb Through Analyst Insights
April 26, 2024
Via
Benzinga
Stock Market Rebounds; Tesla, Microsoft, Google, Meta, Chipotle, GE In Focus: Weekly Review
April 26, 2024
Via
Investor's Business Daily
CHMP Adopts Positive Opinion Recommending Approval of Bristol Myers Squibb’s Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine for the First-Line Treatment of Adult Patients with Unresectable or Metastatic Urothelial Carcinoma
April 26, 2024
From
Bristol Myers Squibb
Via
Business Wire
Investor Sentiment Improves Slightly, But Dow Tumbles Over 350 Points
April 26, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Crude Oil Moves Higher; Bristol Myers Squibb Shares Fall After Q1 Results
April 25, 2024
Via
Benzinga
Exposures
Fossil Fuels
Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 25, 2024
Via
Benzinga
Bristol Myers Squibb Swings To Quarterly Loss, After String Of Multi-Billion Acquisitions
April 25, 2024
Via
Benzinga
PLTR Stock: Palantir Beefs Up Healthcare AI Work Through Parexel Deal
April 25, 2024
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
BMY Stock Earnings: Bristol-Myers Squibb Beats EPS, Beats Revenue for Q1 2024
April 25, 2024
Via
InvestorPlace
Bristol-Myers Squibb Layoffs 2024: What to Know About the Latest BMY Job Cuts
April 25, 2024
Via
InvestorPlace
Topics
Workforce
Exposures
Layoff
Bristol Myers Squibb (BMY) Q1 2024 Earnings Call Transcript
April 25, 2024
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Is Bristol Myers Squibb Stock a Millionaire Maker?
April 25, 2024
Via
The Motley Fool
Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market
April 25, 2024
Via
Investor's Business Daily
AstraZeneca, Sanofi Jump On First-Quarter Earnings; Bristol Myers Lags
April 25, 2024
Via
Investor's Business Daily
Bristol Myers Squibb Reports First Quarter Financial Results for 2024
April 25, 2024
From
Bristol Myers Squibb
Via
Business Wire
Novartis Stock Gains On European Drugmaker's Q1 Earnings Surprise, Lifts Annual Outlook
April 23, 2024
Via
Benzinga
5 Crash-Proof Stocks to Buy Immediately
April 22, 2024
Via
InvestorPlace
US Stocks Brace For Negative Start Amid Tech Earnings Disappointments, Caution Ahead Of Data: 'Worst Of This Two-Week Decline Is Behind Us,' Says Analyst
April 25, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.